{"id":"W4367552266","doi":"10.1093/ehjcvp/pvad032","title":"Antithrombotic treatment strategies in patients with established coronary atherosclerotic disease","year":2023,"lang":"en","type":"review","venue":"European Heart Journal - Cardiovascular Pharmacotherapy","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Abbott Vascular; St. Jude Medical; CytoSorbents Europe; Intas Pharmaceuticals; Idorsia Pharmaceuticals; Terumo; Sanofi; Abiomed; Eisai; Biosensors International Group; Medicure; InfraRedx; Medicines Company; Canada Excellence Research Chairs, Government of Canada; Osprey Medical; Novo Nordisk; Daiichi-Sankyo; Regeneron Pharmaceuticals; Boston Scientific Corporation; Bristol-Myers Squibb; Eli Lilly and Company; Biotronik; AstraZeneca; CSL Behring; Daiichi Sankyo Europe; Servier; Gilead Sciences; Bayer HealthCare; Cilag; Cardinal Health; Edwards Lifesciences; Amgen; Pfizer; Universität Basel","keywords":"Antithrombotic; Medicine; Intensive care medicine; Coronary artery disease; Terminology; Regimen; Fibrinolytic agent; Cardiology; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005217878,0.0008408982,0.003813325,0.00313349,0.0002675492,0.001483561,0.0009136712,0.001275013,0.002644582],"category_scores_gemma":[0.01271975,0.0003949614,0.004814315,0.002993596,0.0003406107,0.001001806,0.000559911,0.001368185,0.0002389717],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009653833,"about_ca_system_score_gemma":0.002217443,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002243378,"about_ca_topic_score_gemma":0.006197637,"domain_scores_codex":[0.9966021,0.001534023,0.001025026,0.0002768494,0.0004828045,0.0000791301],"domain_scores_gemma":[0.9917651,0.006566231,0.001014464,0.0001203582,0.0004839027,0.0000498978],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0008773197,0.00008202141,0.002095791,0.4794361,0.02383422,0.000111483,0.0001367314,0.0005494818,0.0004548581,0.001639489,0.006225143,0.4845573],"study_design_scores_gemma":[0.001389115,0.001152379,0.01612589,0.5636863,0.1945708,0.001450475,0.0004396045,0.0008665886,0.001251643,0.00495998,0.2139928,0.0001143448],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0002351339,0.9992746,0.00006632814,0.0001640122,0.00005595332,0.0000139143,0.00003905855,0.000001288448,0.0001497112],"genre_scores_gemma":[0.006063578,0.9929026,0.0004573473,0.0003060388,0.0001074913,0.00003746065,0.00006790464,0.000001492817,0.00005619349],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005217878,"threshold_uncertainty_score":0.0275951,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07401050145086814,"score_gpt":0.3403840332688821,"score_spread":0.266373531818014,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}